12 Jun 2013
A study from Germany presented at the Society of Nuclear Medicine and Molecular Imaging's 2013 Annual Meeting investigates side effects and survival rates of peptide-receptor radionuclide therapy in a total of 450 patients with neuroendocrine tumours selected by prospective national registry.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024